Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +142.69% | -19.18% | -49.17% | +0.00% | -61.02% |
| Gross Profit Growth | +164.94% | -30.77% | -82.43% | +0.00% | -70.34% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | -200.85% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | -281.34% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.26% | +0.23% | +0.17% | +0.11% | +0.13% |
| Weighted Average Shares Diluted Growth | +0.26% | +63.66% | +0.17% | -37.86% | +0.13% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -73.88% | -77.88% | -86.11% | +74.56% | -65.80% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -12.88% | -12.12% | -27.51% | -25.41% | -8.88% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | +23.49% | +5.10% | -19.80% | -1.50% | +26.62% |
| R&D Expense Growth | +18.89% | +6.58% | -32.27% | -24.55% | -38.60% |
| SG&A Expenses Growth | -3.51% | +4.53% | +2.36% | -23.84% | -15.51% |